Key result
Oral poliovirus vaccine failure is linked to a ~40% higher prevalence of stool viral pathogens.
Why the study?
Identifying the causes of poor oral vaccine immunogenicity in low-income countries could lead to more effective vaccines.
Do immune parameters and infection status predict oral poliovirus vaccine immunogenicity in Indian infants aged 6-11 months?
Observational (n=292)
Double-blind
Randomized
No
Do immune parameters and infection status predict oral poliovirus vaccine immunogenicity in Indian infants aged 6-11 months?
Systemic and fecal immune parameters at the time of vaccination predicted oral poliovirus vaccine seroconversion with only modest accuracy (58%), suggesting that peripheral markers are insufficient to fully explain poor vaccine immunogenicity in low-income settings.
This is the authors' abstract. We don't add key points for this paper.
Identification of the causes of poor oral vaccine immunogenicity in low-income countries might lead to more effective vaccines. We measured mucosal and systemic immune parameters at the time of vaccination with oral poliovirus vaccine (OPV) in 292 Indian infants aged 6–11 months, including plasma cytokines, leukocyte counts, fecal biomarkers of environmental enteropathy and peripheral blood T-cell phenotype, focused on gut-homing regulatory CD4+ populations. We did not find a distinct immune phenotype associated with OPV immunogenicity, although viral pathogens were more prevalent in stool at the time of immunization among infants who failed to seroconvert (63.9% vs. 45.6%, p = 0.002). Using a machine-learning approach, we could predict seroconversion a priori using immune parameters and infection status with a median 58% accuracy (cross-validation IQR: 50–69%) compared with 50% expected by chance. Better identification of immune predictors of OPV immunogenicity is likely to require sampling of mucosal tissue and improved oral poliovirus infection models.
Answers are grounded in this paper and cite their sources.
Peripheral markers predict OPV response with only modest accuracy; extends evidence that enteric viral infections impair immunogenicity in low-resource settings.
No takes yet. Share an insight, caveat, or question.
Babji et al. (2020) conducted an observational in Poor oral vaccine immunogenicity (n=292). Monovalent serotype 3 oral poliovirus vaccine (mOPV3) was evaluated on Prevalence of viral pathogens in stool at the time of immunization (infants who failed to seroconvert vs. those who seroconverted) (p=0.002). Among infants in South India, there was no distinct immune phenotype associated with oral poliovirus vaccine immunogenicity, but viral pathogens were more prevalent in the stool of infants who failed to seroconvert.
Synapse has enriched 10 related papers. Consider them for comparative context: